When Will Stendra Go Generic?
Stendra (avanafil) is anticipated to go generic in 2028 [1]. This projection is based on the typical patent and exclusivity timelines for branded drugs [1].
What Are Stendra's Patents and Exclusivity Dates?
The main patent for Stendra is set to expire in 2028 [1]. Drug patent information can be complex, with multiple patents potentially covering different aspects of a drug's development, formulation, or use. These can influence the timeline for generic entry [1].
How Does Generic Stendra Become Available?
Generic versions of Stendra can enter the market once the principal patents and any associated exclusivity periods have expired [1]. This allows other pharmaceutical companies to produce and sell less expensive bioequivalent versions of the drug [1].
What Happens to Stendra's Price When It Goes Generic?
When a generic version of a drug becomes available, the price typically decreases significantly. This is due to increased competition among manufacturers [1].
Who Makes Stendra?
Stendra is manufactured by Astellas Pharma [2].
What Are Stendra's Approved Uses?
Stendra is prescribed to treat erectile dysfunction (ED) [2].
How Does Stendra Work?
Stendra is a phosphodiesterase type 5 (PDE5) inhibitor. It works by increasing blood flow to the penis during sexual stimulation, which helps men achieve and maintain an erection [2].
Are There Alternatives to Stendra?
Other PDE5 inhibitors, such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra), are also used to treat erectile dysfunction [3].
What Are the Potential Side Effects of Stendra?
Common side effects of Stendra can include headache, flushing, nasal congestion, and back pain [2].
---
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.rxlist.com/stendra-drug.htm
3. https://www.mayoclinic.org/diseases-conditions/erectile-dysfunction/diagnosis-treatment/drc-20355777